chr13	94218511	94218512	rs1572050	Renal sinus fat	chr13	94218436	94218936	501	*	6.64	2.81	7.58	-4.78	2.96e-12	4.36e-11
chr1	16889836	16889837	rs6586513	Allergic rhinitis	chr1	16889394	16889894	501	*	7.45	6.63	7.96	-1.33	0.00781	0.0149
chr15	60585831	60585832	rs340005	Gamma glutamyl transferase levels	chr15	60585703	60586203	501	*	5.46	4.29	6.1	-1.81	0.00997	0.0186
chr12	20320824	20320825	rs7134375	HDL cholesterol	chr12	20320449	20320949	501	*	7.21	6.25	7.79	-1.54	0.0172	0.0305
chr10	79274913	79274914	rs1250542	Multiple sclerosis	chr10	79274665	79275165	501	*	7.58	6.51	8.19	-1.68	0.00126	0.00277
chr2	27519736	27519737	rs780093	Calcium levels	chr2	27519643	27520143	501	*	5.88	1.86	6.83	-4.97	1.47e-08	8.67e-08
chr3	78304441	78304442	rs9831754	Calcium levels	chr3	78304032	78304532	501	*	5.49	3.99	6.21	-2.22	0.00147	0.00321
chr21	16455971	16455972	rs2823819	Attention deficit hyperactivity disorder	chr21	16455921	16456421	501	*	6.86	5.53	7.54	-2.01	5.05e-05	0.000142
chr14	72417166	72417167	rs7159300	Smoking cessation	chr14	72416829	72417329	501	*	5.06	2.15	5.96	-3.82	6.98e-06	2.31e-05
chr3	195137645	195137646	rs2131877	Non-small cell lung cancer	chr3	195137109	195137833	725	*	6.4	2.69	7.34	-4.65	4.22e-12	5.99e-11
chr9	104885374	104885375	rs3890182	HDL cholesterol	chr9	104885173	104885673	501	*	6.89	3.2	7.83	-4.64	3.03e-08	1.66e-07
chr6	3359103	3359104	rs4959235	Antipsychotic drug-induced QTc interval prolongation	chr6	3358986	3359486	501	*	7.16	2.11	8.14	-6.03	9.41e-20	9.12e-18
chr15	89358801	89358802	rs4932217	Height	chr15	89358524	89359024	501	*	7.82	6.99	8.34	-1.36	0.0014	0.00307
chr13	36089165	36089166	rs9315385	Heart rate variability traits	chr13	36089082	36089582	501	*	4.67	3.5	5.31	-1.8	0.0139	0.0252
chr17	36463349	36463350	rs4796217	Protein quantitative trait loci	chr17	36463187	36463687	501	*	5.32	4.42	5.87	-1.45	0.0156	0.028
chr5	99445399	99445400	rs1829883	Hemostatic factors and hematological phenotypes	chr5	99445383	99445883	501	*	4.93	3.23	5.69	-2.46	0.000257	0.00064
chr3	34921177	34921178	rs10514688	Tonometry	chr3	34920473	34921284	812	*	7.04	3.44	7.98	-4.54	4.71e-11	5.16e-10
chr1	186663185	186663186	rs10911902	Schizophrenia	chr1	186662686	186663186	501	*	5.01	2.16	5.91	-3.74	1.3e-06	4.97e-06
chr11	116733008	116733009	rs12272004	Triglycerides	chr11	116732659	116733159	501	*	5.83	4.39	6.54	-2.14	0.000176	0.00045
chr1	106793679	106793680	rs12097821	Non-obstructive azoospermia	chr1	106793567	106794067	501	*	4.72	3.02	5.48	-2.46	0.000664	0.00154
chr9	87620879	87620880	rs11141915	Response to gemcitabine in pancreatic cancer	chr9	87620671	87621171	501	*	8.65	2.31	9.64	-7.33	4.02e-26	1.86e-23
chr1	155135691	155135692	rs12726330	Parkinson's disease	chr1	155135552	155136052	501	*	8.26	7.54	8.74	-1.2	0.00208	0.00442
chr12	39959194	39959195	rs10877840	Parkinson's disease	chr12	39958969	39959469	501	*	6.27	4.48	7.04	-2.56	1.02e-05	3.26e-05
chr15	78540881	78540882	rs12901682	Response to tocilizumab in rheumatoid arthritis	chr15	78540150	78540911	762	*	8.1	7.55	8.49	-0.94	0.0175	0.0309
chr5	126846170	126846171	rs959573	Parkinson's disease (motor and cognition)	chr5	126845821	126846786	966	*	6.44	4.02	7.3	-3.28	8.46e-08	4.17e-07
chr1	159204097	159204098	rs3027009	Lean body mass and age at menarche (combined)	chr1	159203682	159204473	792	*	8.18	7.47	8.65	-1.19	0.0197	0.0346
chr6	25640972	25640973	rs932316	Iron status biomarkers	chr6	25640775	25641275	501	*	8.13	2.69	9.12	-6.42	9e-22	1.4e-19
chr12	41778180	41778181	rs871392	Biochemical measures	chr12	41777954	41778454	501	*	5.03	3.64	5.73	-2.09	0.00284	0.00588
chr3	39514089	39514090	rs864643	Attention deficit hyperactivity disorder	chr3	39513610	39514110	501	*	7.6	2.06	8.59	-6.52	3.57e-18	2.32e-16
chr22	21953147	21953148	rs412050	Attention deficit hyperactivity disorder	chr22	21952676	21953176	501	*	6.28	5.59	6.74	-1.16	0.0269	0.0457
chr5	112907271	112907272	rs469727	Attention deficit hyperactivity disorder	chr5	112907063	112907793	731	*	7.45	6.78	7.9	-1.13	0.0137	0.0248
chr2	42754099	42754100	rs930421	Attention deficit hyperactivity disorder	chr2	42753979	42754479	501	*	7.58	6.2	8.28	-2.07	3.91e-05	0.000112
chr11	5204405	5204406	rs11036238	Malaria	chr11	5204341	5204841	501	*	6.29	4.37	7.09	-2.71	0.000608	0.00142
chr4	9921380	9921381	rs734553	Uric acid levels	chr4	9921289	9921789	501	*	4.93	1.29	5.87	-4.58	5.07e-07	2.11e-06
chr15	55094545	55094546	rs1528473	Inflammatory skin disease	chr15	55094105	55094605	501	*	6.1	4.23	6.88	-2.65	0.00109	0.00243
chr8	95196498	95196499	rs4484658	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	chr8	95196342	95196842	501	*	5.29	3.43	6.08	-2.65	0.000101	0.00027
chr10	37101682	37101683	rs1200921	Breast cancer	chr10	37101276	37101776	501	*	6.09	3.16	6.99	-3.83	4.75e-07	1.99e-06
chr2	69207095	69207096	rs12474538	Breast cancer	chr2	69206824	69207324	501	*	5.82	2.69	6.74	-4.05	1.68e-06	6.27e-06
chr22	29581329	29581330	rs183421746	Breast cancer	chr22	29580939	29581439	501	*	6.04	4.84	6.68	-1.84	0.00067	0.00155
chr9	107541528	107541529	rs60037937	Breast cancer	chr9	107541440	107541940	501	*	5.52	1.04	6.49	-5.45	6.1e-10	5.04e-09
chr2	217858732	217858733	rs6436017	Breast cancer	chr2	217858397	217858897	501	*	7.1	3	8.06	-5.06	1.86e-09	1.36e-08
chr11	66843174	66843175	rs7570	Breast cancer	chr11	66843163	66843663	501	*	7.6	6.71	8.15	-1.44	0.0069	0.0133
chr10	105187248	105187249	rs1947988	Cognitive ability	chr10	105187129	105187629	501	*	8.72	2.42	9.71	-7.3	6.75e-27	3.55e-24
chr10	127338145	127338146	rs4751240	Body mass index (change over time) in gastrointestinal cancer	chr10	127337818	127338318	501	*	6.92	5.29	7.66	-2.37	0.000126	0.00033
chr6	33080912	33080913	rs141530233	Antineutrophil cytoplasmic antibody-associated vasculitis	chr6	33080114	33080945	832	*	8.07	6.73	8.75	-2.01	0.000238	0.000594
chr4	15707629	15707630	rs2302464	Cerebrospinal fluid biomarker levels	chr4	15707309	15707809	501	*	5.53	1.51	6.48	-4.98	2.31e-09	1.66e-08
chr16	1706177	1706178	rs6600164	Intraocular pressure	chr16	1705885	1706385	501	*	7.61	6.9	8.08	-1.18	0.0118	0.0217
chr3	64716599	64716600	rs4616635	Waist-to-hip ratio adjusted for BMI x sex interaction	chr3	64716270	64716770	501	*	8.06	3.18	9.04	-5.86	8.83e-14	1.92e-12
chr19	35396227	35396228	rs16970288	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	chr19	35395827	35396327	501	*	5.65	-0.21	6.64	-6.85	2.63e-08	1.47e-07
chr16	21599483	21599484	rs1478461	Depression (broad)	chr16	21599235	21599735	501	*	8.47	7.14	9.15	-2.01	1.05e-07	5.05e-07
chr1	221714561	221714562	rs72736544	Rheumatic fever	chr1	221714339	221714839	501	*	6.6	2.15	7.57	-5.42	2.06e-10	1.91e-09
chr3	143241431	143241432	rs4839604	N-glycan levels	chr3	143241377	143241877	501	*	6.83	3.4	7.76	-4.36	6.91e-08	3.48e-07
chr2	62341310	62341311	rs6759298	Ankylosing spondylitis	chr2	62340968	62341468	501	*	5.7	0.42	6.68	-6.26	3.82e-10	3.33e-09
chr2	104434714	104434715	rs7562028	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	chr2	104434339	104434839	501	*	5.81	3.91	6.6	-2.69	4.14e-06	1.43e-05
chr18	26757460	26757461	rs527616	Breast cancer	chr18	26757213	26757713	501	*	6.39	2.06	7.36	-5.3	2.05e-11	2.46e-10
chr6	160668275	160668276	rs56393506	Ischemic stroke (large artery atherosclerosis)	chr6	160667828	160668328	501	*	4.99	1.82	5.91	-4.08	2.69e-07	1.19e-06
chr7	100561944	100561945	rs2734897	Alzheimer's disease or family history of Alzheimer's disease	chr7	100561667	100562167	501	*	7.48	4.01	8.41	-4.4	3.48e-15	1.07e-13
chr19	44845920	44845921	rs77241309	Alzheimer's disease or family history of Alzheimer's disease	chr19	44845819	44846319	501	*	6.2	-0.21	7.19	-7.39	1.3e-10	1.27e-09
chr17	7851675	7851676	rs12939056	Height	chr17	7851674	7852174	501	*	7.61	6.91	8.09	-1.18	0.00941	0.0176
chr3	52979251	52979252	rs62253653	Hand grip strength	chr3	52978982	52979482	501	*	5.72	2.01	6.66	-4.65	1.15e-05	3.65e-05
chr7	86965067	86965068	rs6958716	Seborrheic dermatitis	chr7	86964703	86965203	501	*	6.08	4.97	6.69	-1.72	0.00173	0.00372
chr1	155061442	155061443	rs41264285	Systemic lupus erythematosus	chr1	155061410	155061910	501	*	5.27	3.79	5.98	-2.19	0.000414	0.000993
chr7	22726602	22726603	rs1800797	Systemic lupus erythematosus	chr7	22726319	22726819	501	*	4.52	2.84	5.27	-2.43	0.00172	0.0037
chr1	161566341	161566342	rs332398	Systemic lupus erythematosus	chr1	161566134	161566634	501	*	4.9	2.53	5.75	-3.23	3.13e-05	9.15e-05
chr16	10944503	10944504	rs8054198	Systemic lupus erythematosus	chr16	10944218	10944718	501	*	9.25	7.91	9.94	-2.03	5.28e-09	3.47e-08
chr1	161727208	161727209	rs1875763	White blood cell count	chr1	161726752	161727252	501	*	7.15	5.01	7.98	-2.97	2.53e-09	1.8e-08
chr6	33080823	33080824	rs116722486	White blood cell count	chr6	33080114	33080945	832	*	8.07	6.73	8.75	-2.01	0.000238	0.000594
chr16	30091839	30091840	rs3809627	Red blood cell count	chr16	30091759	30092259	501	*	6.59	5.45	7.23	-1.78	0.00222	0.00469
chr17	49789170	49789171	rs1123339	Mean corpuscular volume	chr17	49788898	49789398	501	*	8.88	7.66	9.53	-1.87	1.43e-05	4.44e-05
chr15	101015194	101015195	rs2034809	Central corneal thickness	chr15	101015160	101015660	501	*	4.73	3.61	5.35	-1.74	0.0219	0.038
chr2	113974664	113974665	rs12472051	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	chr2	113974616	113975116	501	*	7.39	5.81	8.12	-2.31	0.000377	0.000911
chr15	73371562	73371563	rs7173389	Resting heart rate	chr15	73371357	73371857	501	*	5.58	0.73	6.56	-5.83	7.74e-09	4.9e-08
chr8	19682127	19682128	rs7816924	Response to antidepressant treatment (citalopram)	chr8	19682026	19682526	501	*	8.5	3.73	9.47	-5.74	2.94e-32	4.68e-29
chr12	47377646	47377647	rs2074193	Migraine with aura	chr12	47377436	47377936	501	*	6.89	5.86	7.48	-1.62	0.0199	0.0349
chr17	59210093	59210094	rs6503905	Circulating myeloperoxidase levels (plasma)	chr17	59209772	59210272	501	*	6.32	5.38	6.89	-1.51	0.00423	0.00849
chr3	171116770	171116771	rs11920719	LDL cholesterol	chr3	171116284	171116784	501	*	6.14	4.17	6.94	-2.77	0.00102	0.00229
chr2	206781950	206781951	rs7594645	Episodic memory	chr2	206781502	206782002	501	*	5.99	2.73	6.91	-4.18	6.03e-10	4.99e-09
chr6	158537074	158537075	rs930451	Breastfeeding duration	chr6	158536408	158537396	989	*	7.22	5.89	7.9	-2.01	0.00092	0.00208
chr1	223732743	223732744	rs140084787	Febrile seizures (MMR vaccine-related)	chr1	223732395	223732895	501	*	6.43	1.89	7.4	-5.51	1.34e-12	2.16e-11
chr11	15843741	15843742	rs11023737	Longevity (90 years and older)	chr11	15843485	15843985	501	*	6.33	5.57	6.83	-1.26	0.0186	0.0328
chr6	79612564	79612565	rs6917843	Very long-chain saturated fatty acid levels (fatty acid 20:0)	chr6	79612417	79612917	501	*	6.52	3.37	7.44	-4.07	1.16e-07	5.52e-07
chr1	11838976	11838977	rs1023252	Natriuretic peptide levels	chr1	11838633	11839133	501	*	4.76	3.44	5.44	-2	0.0059	0.0115
chr5	35803475	35803476	rs931555	Multiple sclerosis	chr5	35803052	35803552	501	*	7.4	6.28	8.02	-1.74	0.00503	0.00993
chr1	167442147	167442148	rs864537	Celiac disease or Rheumatoid arthritis	chr1	167442085	167442585	501	*	6.25	5.34	6.81	-1.47	0.0282	0.0477
chr5	142638295	142638296	rs152528	Cardiac hypertrophy	chr5	142637876	142638376	501	*	5.36	4.55	5.87	-1.32	0.0256	0.0438
chr8	27608798	27608799	rs1532278	Alzheimer's disease (late onset)	chr8	27608602	27609102	501	*	8.63	7.84	9.13	-1.3	0.00101	0.00226
chr4	163611649	163611650	rs3792615	Type 2 diabetes	chr4	163611599	163612099	501	*	6.36	2.48	7.31	-4.82	2e-09	1.46e-08
chr8	32554841	32554842	rs2439312	Dialysis-related mortality	chr8	32554599	32555099	501	*	6.44	3.87	7.32	-3.45	1.6e-09	1.19e-08
chr3	74585946	74585947	rs1374879	Smoking quantity	chr3	74585879	74586379	501	*	6.54	2.98	7.48	-4.5	1.98e-11	2.39e-10
chr4	95537282	95537283	rs10032931	Optic nerve measurement (cup-to-disc ratio)	chr4	95537090	95537590	501	*	5.77	4.55	6.42	-1.87	0.000965	0.00217
chr7	115274554	115274555	rs10274759	PR interval in Tripanosoma cruzi seropositivity	chr7	115274383	115274883	501	*	6.06	2.4	7	-4.61	4.4e-09	2.95e-08
chr19	3435547	3435548	rs72974768	QRS duration in Tripanosoma cruzi seropositivity	chr19	3435058	3435558	501	*	6.56	5.8	7.06	-1.26	0.0129	0.0236
chr10	58908811	58908812	rs61458523	QT interval in Tripanosoma cruzi seropositivity	chr10	58908623	58909123	501	*	7.5	3.2	8.47	-5.27	3.81e-14	9.06e-13
chr5	144031781	144031782	rs391760	Bipolar disorder (body mass index interaction)	chr5	144031445	144031945	501	*	5.92	1.29	6.89	-5.6	3.87e-09	2.63e-08
chr6	167120802	167120803	rs3093023	Rheumatoid arthritis	chr6	167120329	167120829	501	*	4.68	1.51	5.6	-4.09	5.79e-06	1.94e-05
chr4	178480279	178480280	rs2702449	Response to mTOR inhibitor (everolimus)	chr4	178480049	178480549	501	*	6.11	5.2	6.67	-1.46	0.0122	0.0223
chr2	229657682	229657683	rs1861612	Type 2 diabetes	chr2	229657498	229657998	501	*	6.34	2.79	7.28	-4.49	7.21e-13	1.24e-11
chr7	8118257	8118258	rs6463768	Metabolite levels (Pyroglutamine)	chr7	8117980	8118480	501	*	5.12	3.21	5.92	-2.71	0.00321	0.00659
chr17	45135596	45135597	rs2291447	Economic and political preferences	chr17	45135247	45135747	501	*	7.58	6.74	8.11	-1.38	0.00668	0.0129
chr19	45692498	45692499	rs7245708	Subcutaneous adipose tissue	chr19	45691731	45692702	972	*	9.17	7.89	9.84	-1.95	4.26e-06	1.47e-05
chr1	38136401	38136402	rs7547921	Visceral adipose tissue/subcutaneous adipose tissue ratio	chr1	38135947	38136806	860	*	6.73	4.13	7.61	-3.48	6.32e-10	5.2e-09
chr18	26312708	26312709	rs1791780	Visceral adipose tissue adjusted for BMI	chr18	26312325	26312825	501	*	5.49	4.72	5.99	-1.28	0.0264	0.0449
chr6	129710348	129710349	rs17057678	Antineutrophil cytoplasmic antibody-associated vasculitis	chr6	129709993	129710493	501	*	5.62	3.64	6.42	-2.78	0.000101	0.00027
chr1	153876520	153876521	rs7414227	Lentiform nucleus volume	chr1	153876310	153876810	501	*	4.72	0.33	5.69	-5.36	5.17e-07	2.15e-06
chr3	185424069	185424070	rs7629245	Airflow obstruction	chr3	185423608	185424108	501	*	5.9	2.4	6.84	-4.44	2.59e-10	2.35e-09
chr22	26645319	26645320	rs16982515	IgG glycosylation	chr22	26645220	26645720	501	*	5.63	4.44	6.28	-1.83	0.00192	0.0041
chr8	28324238	28324239	rs11779594	IgG glycosylation	chr8	28324207	28324707	501	*	6.39	5.18	7.04	-1.86	0.000387	0.000933
chr6	126530014	126530015	rs1490384	Height	chr6	126529556	126530056	501	*	5.63	4.24	6.32	-2.08	0.00087	0.00197
chr16	53811575	53811576	rs11642841	Type 2 diabetes	chr16	53811117	53811617	501	*	3.95	1.29	4.83	-3.54	0.000334	0.000814
chr1	153801800	153801801	rs4434872	Conduct disorder (symptom count)	chr1	153801456	153802419	964	*	6.52	4.94	7.25	-2.32	1.21e-05	3.82e-05
chr13	93226778	93226779	rs7985891	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	chr13	93226575	93227075	501	*	7.43	2.9	8.4	-5.5	9.01e-21	1.12e-18
chr7	8103297	8103298	rs7791362	Cognitive function	chr7	8103120	8104104	985	*	7.3	6.42	7.84	-1.42	0.0063	0.0122
chr1	45618711	45618712	rs1053941	Blood metabolite levels	chr1	45618354	45618854	501	*	5.53	0.85	6.5	-5.65	8.93e-09	5.57e-08
chr1	62734265	62734266	rs6679002	Blood metabolite levels	chr1	62733783	62734283	501	*	6.87	1.04	7.86	-6.82	2.21e-12	3.35e-11
chr18	49645913	49645914	rs2187375	Blood metabolite levels	chr18	49645655	49646155	501	*	8.92	6.66	9.76	-3.1	1.84e-14	4.72e-13
chr1	205750404	205750405	rs823114	Parkinson's disease	chr1	205750071	205750571	501	*	9.02	8.37	9.47	-1.11	0.00133	0.00292
chr2	103419975	103419976	rs13390641	Blood pressure (anthropometric measures interaction)	chr2	103419522	103420022	501	*	6.22	2.96	7.14	-4.18	1.12e-08	6.82e-08
chr1	47388842	47388843	rs17103186	Corneal curvature	chr1	47388680	47389180	501	*	5.56	4	6.29	-2.29	0.000676	0.00156
chr9	127348132	127348133	rs7029536	Metabolite levels (HVA)	chr9	127348027	127348527	501	*	4.44	2.4	5.25	-2.85	0.000264	0.000655
chr17	36949012	36949013	rs2306658	Obesity-related traits	chr17	36948621	36949121	501	*	8.26	7.62	8.71	-1.09	0.0257	0.0439
chr16	27203663	27203664	rs16976587	Obesity-related traits	chr16	27203265	27204172	908	*	9.08	7.8	9.75	-1.95	5.15e-05	0.000145
chr10	5876469	5876470	rs17145612	Obesity-related traits	chr10	5876353	5876853	501	*	6.46	2.93	7.4	-4.46	5.74e-13	1.01e-11
chr3	139354169	139354170	rs1044826	Obesity-related traits	chr3	139353893	139354393	501	*	5.87	3.57	6.71	-3.14	4.53e-06	1.55e-05
chr7	49594206	49594207	rs4492324	Obesity-related traits	chr7	49594165	49594665	501	*	5.47	3.37	6.3	-2.93	3.8e-05	0.000109
chr15	78618839	78618840	rs8040868	Obesity-related traits	chr15	78618362	78618862	501	*	6.15	3.34	7.04	-3.7	1.08e-09	8.38e-09
chr20	12241517	12241518	rs6134479	Hearing function	chr20	12241303	12241803	501	*	7.03	3.13	7.98	-4.86	2.08e-12	3.18e-11
chr8	108083801	108083802	rs374810	Ossification of the posterior longitudinal ligament of the spine	chr8	108083421	108083921	501	*	6.66	4.22	7.52	-3.3	1.52e-05	4.72e-05
chr7	27745330	27745331	rs10214930	Hypospadias	chr7	27745029	27745529	501	*	6.03	4.87	6.66	-1.79	0.00233	0.00491
chr6	41654359	41654360	rs45483501	Diffuse large B cell lymphoma	chr6	41654348	41654848	501	*	5.12	0.33	6.09	-5.76	2.74e-08	1.52e-07
chr11	123523928	123523929	rs77502336	Schizophrenia	chr11	123523479	123523979	501	*	6.12	3.64	6.98	-3.35	4.14e-07	1.75e-06
chr13	50545001	50545002	rs1239954	Obesity-related traits	chr13	50544605	50545105	501	*	6.99	2.26	7.97	-5.7	9.95e-19	7.52e-17
chr9	94681756	94681757	rs10125337	Obesity-related traits	chr9	94681401	94681901	501	*	6.02	4.88	6.65	-1.77	0.0193	0.0339
chr3	143286187	143286188	rs17636071	Response to cholinesterase inhibitors in Alzheimer's disease	chr3	143285845	143286345	501	*	5.24	2.42	6.14	-3.71	1.76e-06	6.56e-06
chr11	125443703	125443704	rs7930295	Schizophrenia	chr11	125443681	125444181	501	*	7.72	4.76	8.63	-3.86	1.17e-15	4.03e-14
chr10	107614626	107614627	rs11193561	Endometriosis	chr10	107614392	107614892	501	*	7.39	3.15	8.35	-5.2	2.2e-16	9.24e-15
chr8	1295964	1295965	rs17669535	Menarche (age at onset)	chr8	1295661	1296161	501	*	5.98	-0.21	6.97	-7.18	1.45e-09	1.1e-08
chr2	218607602	218607603	rs611203	Height	chr2	218607473	218607973	501	*	7.29	2.49	8.27	-5.78	6.81e-14	1.53e-12
chr12	87960746	87960747	rs11104688	Trans fatty acid levels	chr12	87960574	87961074	501	*	4.88	1.38	5.82	-4.44	7.22e-07	2.91e-06
chr7	14242285	14242286	rs17765925	Verbal declarative memory	chr7	14242232	14242732	501	*	7.39	4.63	8.28	-3.65	2.47e-10	2.26e-09
chr21	36112764	36112765	rs4817775	Bone mineral density	chr21	36112700	36113451	752	*	7.69	7.05	8.14	-1.09	0.0095	0.0178
chr12	3804261	3804262	rs2058350	Cognitive performance	chr12	3803806	3804306	501	*	5.36	3.81	6.09	-2.27	0.000356	0.000866
chr1	222750009	222750010	rs6683071	Cognitive performance	chr1	222749872	222750372	501	*	5.38	3.85	6.11	-2.25	0.0116	0.0213
chr1	210362681	210362682	rs7527939	Schizophrenia	chr1	210362484	210362984	501	*	5.31	-0.21	6.29	-6.5	4.73e-08	2.47e-07
chr6	7743430	7743431	rs9505270	Myopia (pathological)	chr6	7743164	7743664	501	*	5.87	2.22	6.81	-4.6	3.15e-10	2.8e-09
chr10	6273831	6273832	rs7077335	Myopia (pathological)	chr10	6273381	6273881	501	*	6.01	3.2	6.9	-3.7	6.38e-06	2.12e-05
chr6	33080884	33080885	rs1042151	Aspirin exacerbated respiratory disease in asthmatics	chr6	33080114	33080945	832	*	8.07	6.73	8.75	-2.01	0.000238	0.000594
chr19	17309480	17309481	rs2303745	Systemic lupus erythematosus	chr19	17309196	17309696	501	*	7.81	6.71	8.42	-1.71	0.000126	0.00033
chr5	51632976	51632977	rs4865673	Dental caries	chr5	51632720	51633220	501	*	6.06	3.79	6.91	-3.11	2.47e-05	7.36e-05
chr20	63666449	63666450	rs6011002	Dental caries	chr20	63666159	63666659	501	*	5.2	2.9	6.04	-3.14	1.8e-05	5.5e-05
chr12	47779569	47779570	rs4760636	Urate levels	chr12	47779218	47779718	501	*	8.3	7.6	8.76	-1.16	0.00844	0.016
chr6	6317893	6317894	rs3024321	End-stage coagulation	chr6	6317839	6318339	501	*	6.29	0.85	7.27	-6.42	5.32e-13	9.48e-12
chr2	178873542	178873543	rs11693319	Blood pressure measurement (cold pressor test)	chr2	178873458	178873958	501	*	5.92	2.92	6.83	-3.91	2.26e-06	8.23e-06
chr7	137844832	137844833	rs6978230	Cognitive decline (age-related)	chr7	137844656	137845156	501	*	6.89	5.49	7.59	-2.1	1.38e-05	4.31e-05
chr3	58020539	58020540	rs6764184	Optic cup area	chr3	58020280	58020780	501	*	5.68	3.24	6.54	-3.3	2.38e-06	8.62e-06
chr17	39244798	39244799	rs11078895	Calcium levels	chr17	39244680	39245180	501	*	5.88	4.32	6.61	-2.29	0.000109	0.000288
chr1	241610984	241610985	rs16841877	Number of children	chr1	241610970	241611470	501	*	4.72	3.55	5.35	-1.8	0.0131	0.0238
chr1	7053052	7053053	rs11120822	Stearic acid (18:0) levels	chr1	7052709	7053209	501	*	4.87	0.33	5.84	-5.51	1.53e-07	7.11e-07
chr15	60618351	60618352	rs3784609	Total ventricular volume (Alzheimer's disease interaction)	chr15	60618144	60618644	501	*	6.22	4.3	7.02	-2.71	2.13e-05	6.41e-05
chr7	2723468	2723469	rs798544	Height	chr7	2723221	2723721	501	*	5.91	2.71	6.82	-4.11	2.57e-08	1.43e-07
chr5	177390635	177390636	rs6420094	Chronic kidney disease	chr5	177390404	177390904	501	*	5.76	4.85	6.32	-1.47	0.00934	0.0175
chr12	75889574	75889575	rs11180732	Glomerular filtration rate (creatinine)	chr12	75889098	75889598	501	*	6.62	5.55	7.23	-1.68	0.00252	0.00528
chr2	200306468	200306469	rs10931898	Information processing speed	chr2	200306258	200306758	501	*	8.71	8.03	9.18	-1.15	0.0176	0.0312
chr8	58480714	58480715	rs4738684	Cholesterol, total	chr8	58480330	58480830	501	*	5.49	3.01	6.36	-3.35	1.36e-06	5.19e-06
chr3	127974574	127974575	rs16839633	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	chr3	127974200	127974700	501	*	5.16	2.27	6.05	-3.79	1.44e-05	4.47e-05
chr4	43849075	43849076	rs13146780	Alzheimer's disease in APOE e4- carriers	chr4	43848750	43849250	501	*	5.97	3.59	6.83	-3.24	3.4e-05	9.89e-05
chr10	80494291	80494292	rs6586030	Inflammatory bowel disease	chr10	80494015	80494515	501	*	6.88	2.56	7.84	-5.28	5.51e-16	2.09e-14
chr21	15445619	15445620	rs2823286	Inflammatory bowel disease	chr21	15445246	15445746	501	*	6.84	2.31	7.81	-5.5	2.2e-12	3.35e-11
chr15	32718211	32718212	rs2293582	Colorectal cancer	chr15	32717739	32718239	501	*	7.43	-0.21	8.43	-8.64	2.44e-14	6.07e-13
chr6	32668587	32668588	rs9274657	Autism spectrum disorder or schizophrenia	chr6	32668419	32668919	501	*	6.69	3.08	7.63	-4.56	3.06e-13	5.78e-12
chr6	32668836	32668837	rs147875011	Autism spectrum disorder or schizophrenia	chr6	32668419	32668919	501	*	6.69	3.08	7.63	-4.56	3.06e-13	5.78e-12
chr2	218323178	218323179	rs1870125	Monocyte count	chr2	218322925	218323425	501	*	8.7	7.66	9.3	-1.64	0.000108	0.000285
chr6	33080829	33080830	rs1042133	Monocyte count	chr6	33080114	33080945	832	*	8.07	6.73	8.75	-2.01	0.000238	0.000594
chr8	47739071	47739072	rs45577137	Monocyte count	chr8	47738773	47739273	501	*	6.75	5.26	7.46	-2.2	7.92e-06	2.59e-05
chr13	109159738	109159739	rs75900305	Monocyte count	chr13	109159492	109159992	501	*	5.85	2.87	6.76	-3.89	1.88e-09	1.37e-08
chr7	71149860	71149861	rs56212584	Lung cancer in ever smokers	chr7	71149557	71150057	501	*	5.52	1.69	6.47	-4.78	1.53e-08	9.02e-08
chr4	38656198	38656199	rs75504410	Eosinophil counts	chr4	38655819	38656319	501	*	5.19	1.58	6.13	-4.55	3.16e-08	1.72e-07
chr3	99972678	99972679	rs68092024	Cleft lip with or without cleft palate	chr3	99972290	99972790	501	*	5	3.39	5.75	-2.36	0.000611	0.00142
chr1	155208991	155208992	rs760077	Urea levels	chr1	155208980	155209480	501	*	5.88	4.59	6.55	-1.96	0.00054	0.00127
chr5	16617813	16617814	rs75869162	Urate levels	chr5	16617619	16618119	501	*	7.84	6.2	8.59	-2.39	4.38e-05	0.000125
chr12	50661925	50661926	rs1521516	Fibrinogen levels	chr12	50661748	50662248	501	*	5.01	3.25	5.78	-2.52	0.000955	0.00215
chr1	65687680	65687681	rs4655582	Fibrinogen levels	chr1	65687654	65688154	501	*	6.84	5.95	7.39	-1.44	0.0132	0.0239
chr16	53510718	53510719	rs17193922	Hip circumference adjusted for BMI	chr16	53510353	53510853	501	*	5.68	3.55	6.51	-2.96	1.5e-06	5.66e-06
chr16	28846324	28846325	rs7187776	Hip circumference adjusted for BMI	chr16	28846279	28846779	501	*	8.98	8.02	9.56	-1.54	0.0014	0.00306
chr9	26754898	26754899	rs73642995	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	chr9	26754473	26754973	501	*	6.4	3.8	7.28	-3.48	1.33e-09	1.01e-08
chr7	76226193	76226194	rs11770797	Blood protein levels	chr7	76225866	76226366	501	*	6.72	3.45	7.64	-4.19	7.1e-13	1.23e-11
chr19	40777460	40777461	rs2233159	Blood protein levels	chr19	40777344	40778327	984	*	8.13	7.43	8.6	-1.17	0.00748	0.0143
chr8	21616538	21616539	rs10503709	Blood protein levels	chr8	21616267	21616767	501	*	5.53	-0.21	6.51	-6.72	1.01e-08	6.19e-08
chr12	101823942	101823943	rs10860794	Blood protein levels	chr12	101823903	101824403	501	*	8.94	6	9.84	-3.84	1.83e-18	1.29e-16
chr6	166956742	166956743	rs2247314	Vitiligo	chr6	166956405	166956905	501	*	7.9	6.81	8.51	-1.71	0.00556	0.0109
chr2	24435925	24435926	rs1545257	Sjögren's syndrome	chr2	24435459	24435959	501	*	4.93	1.82	5.84	-4.02	1.96e-06	7.21e-06
chr16	11100223	11100224	rs3862469	Alopecia areata	chr16	11100126	11100626	501	*	6.92	6.05	7.46	-1.41	0.00664	0.0128
chr9	14247347	14247348	rs13286037	Ankle injury	chr9	14247261	14247761	501	*	6.46	3.45	7.37	-3.92	2.38e-07	1.06e-06
chr1	231422308	231422309	rs533281866	Red blood cell count	chr1	231422150	231422650	501	*	8.49	7.7	9	-1.31	0.0027	0.00562
chr4	87123184	87123185	rs13108043	Red blood cell count	chr4	87123170	87123670	501	*	5.9	2.96	6.8	-3.84	1.1e-09	8.5e-09
chr6	43774889	43774890	rs833070	Red blood cell count	chr6	43774657	43775157	501	*	5.75	4.88	6.29	-1.41	0.011	0.0203
chr1	161749589	161749590	rs953301	Left atrial antero-posterior diameter	chr1	161749473	161750496	1024	*	9.38	8.71	9.83	-1.12	0.00332	0.00679
chr12	53046995	53046996	rs73099903	Systolic blood pressure	chr12	53046821	53047321	501	*	6.98	6.31	7.43	-1.12	0.0211	0.0368
chr19	48872268	48872269	rs17272694	Reticulocyte fraction of red cells	chr19	48872090	48872590	501	*	7.33	6.47	7.86	-1.39	0.0025	0.00524
chr19	1164199	1164200	rs35971149	Reticulocyte fraction of red cells	chr19	1164054	1164554	501	*	5.14	2.53	6.02	-3.5	1.56e-05	4.82e-05
chr1	55826667	55826668	rs3935996	Reticulocyte fraction of red cells	chr1	55826227	55826727	501	*	6.4	5.17	7.05	-1.89	0.00115	0.00256
chr10	79282718	79282719	rs1250573	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	chr10	79282713	79283213	501	*	5.56	4.11	6.26	-2.16	0.00023	0.000576
chr8	69663895	69663896	rs4738017	Cervical cancer	chr8	69663707	69664207	501	*	6.92	6.02	7.48	-1.46	0.0108	0.0201
chr17	7703404	7703405	rs7640	Cognitive function	chr17	7703379	7703879	501	*	4.65	1.38	5.57	-4.2	1.83e-06	6.79e-06
chr17	57834081	57834082	rs1443267	Obstetric antiphospholipid syndrome	chr17	57834003	57834503	501	*	5.71	2.11	6.64	-4.53	2.02e-10	1.88e-09
chr16	67424348	67424349	rs6499129	Waist-to-hip ratio adjusted for body mass index	chr16	67424188	67424688	501	*	5.63	-0.21	6.62	-6.83	7.17e-09	4.57e-08
chr3	166498515	166498516	rs73161363	Facial morphology (factor 10, width of nasal floor)	chr3	166498440	166498940	501	*	5.34	2.26	6.26	-3.99	2.7e-08	1.5e-07
chr18	11872893	11872894	rs12456112	Facial morphology (factor 14, intercanthal width)	chr18	11872434	11872934	501	*	5.11	2.78	5.96	-3.19	6.01e-06	2.01e-05
chr2	2517476	2517477	rs1706867	Facial morphology (factor 14, intercanthal width)	chr2	2517069	2517569	501	*	6.51	2.53	7.47	-4.94	2.58e-10	2.34e-09
chr7	105644232	105644233	rs17150689	Facial morphology (factor 14, intercanthal width)	chr7	105643877	105644377	501	*	6.01	4.88	6.63	-1.75	0.0026	0.00543
chr22	21630090	21630091	rs3747093	Systemic lupus erythematosus	chr22	21629863	21630363	501	*	7.09	6.48	7.52	-1.04	0.0264	0.0449
chr6	35066077	35066078	rs820077	Systemic lupus erythematosus	chr6	35065841	35066341	501	*	6.2	1.69	7.16	-5.47	7.54e-12	1.01e-10
chr17	46286843	46286844	rs2732614	Sense of smell	chr17	46286595	46287095	501	*	5.81	4.68	6.44	-1.76	0.0162	0.0289
chr1	246689898	246689899	rs6413860	Gut microbiome composition (summer)	chr1	246689443	246689943	501	*	5.69	4.58	6.32	-1.74	0.00221	0.00468
chr3	157831833	157831834	rs139873132	Post bronchodilator FEV1	chr3	157831334	157831834	501	*	6.06	2.19	7.01	-4.82	9.59e-09	5.93e-08
chr15	78437971	78437972	rs17483548	Post bronchodilator FEV1	chr15	78437862	78438362	501	*	8.95	8.47	9.31	-0.85	0.0157	0.0281
chr4	144537332	144537333	rs11936476	Post bronchodilator FEV1	chr4	144537022	144537522	501	*	7.08	3.66	8.01	-4.35	8.46e-12	1.12e-10
chr15	78540490	78540491	rs3813570	Post bronchodilator FEV1	chr15	78540150	78540911	762	*	8.1	7.55	8.49	-0.94	0.0175	0.0309
chr15	78482334	78482335	rs10851906	Post bronchodilator FEV1	chr15	78482289	78482789	501	*	4.93	1.29	5.87	-4.58	7.04e-07	2.84e-06
chr10	80505515	80505516	rs9633740	Post bronchodilator FEV1	chr10	80505492	80505992	501	*	7.39	6.02	8.08	-2.06	4.52e-06	1.55e-05
chr4	23949395	23949396	rs12501032	Resting heart rate	chr4	23949165	23949665	501	*	5.93	5.12	6.45	-1.34	0.0176	0.0311
chr1	223684349	223684350	rs12137025	Carotenoid levels (alpha-carotene)	chr1	223684131	223684631	501	*	5.82	4.77	6.42	-1.65	0.0031	0.00637
chr10	124849256	124849257	rs11245387	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	chr10	124849092	124849592	501	*	10	9.38	10.44	-1.06	0.0188	0.0331
chr17	55296189	55296190	rs11079159	QRS duration	chr17	55295853	55296353	501	*	6.61	5.53	7.22	-1.69	0.00202	0.00431
chr15	74598640	74598641	rs62005807	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	chr15	74598177	74598677	501	*	8.21	6.97	8.87	-1.9	4.51e-06	1.55e-05
chr3	50396536	50396537	rs2282752	Age at voice drop	chr3	50396457	50396957	501	*	6.07	2.49	7	-4.52	8.12e-08	4.02e-07
chr8	11427626	11427627	rs12156238	Cisplatin-induced ototoxicity	chr8	11427157	11427657	501	*	6.01	2.15	6.96	-4.82	9.65e-10	7.6e-09
chr1	177796886	177796887	rs75608493	Schizophrenia	chr1	177796817	177797317	501	*	6.53	1.86	7.5	-5.64	1.17e-10	1.16e-09
chr11	134426490	134426491	rs893949	Schizophrenia	chr11	134426053	134426553	501	*	5.48	1.29	6.44	-5.15	2.33e-09	1.67e-08
chr8	138953555	138953556	rs36056951	Cerebrospinal T-tau levels	chr8	138953130	138953630	501	*	5.2	3.37	5.98	-2.62	4.78e-05	0.000135
chr20	41147406	41147407	rs760762	Age-related disease endophenotypes	chr20	41147100	41147600	501	*	5.02	3.72	5.69	-1.97	0.0026	0.00544
chr5	170389767	170389768	rs75070487	Response to paliperidone in schizophrenia (negative Marder score)	chr5	170389461	170389961	501	*	5.85	3.53	6.7	-3.18	2.85e-06	1.02e-05
chr6	15691547	15691548	rs59112743	Multiple keratinocyte cancers	chr6	15691208	15691708	501	*	7.81	6.78	8.4	-1.61	0.00141	0.00308
chr1	107793911	107793912	rs17020055	Hypothyroidism	chr1	107793898	107794398	501	*	7.87	5.31	8.74	-3.44	5.53e-13	9.83e-12
chr6	104940530	104940531	rs7766336	Menarche (age at onset)	chr6	104940287	104940787	501	*	6.69	2.29	7.65	-5.36	2.05e-14	5.2e-13
chr4	80285223	80285224	rs4690116	Male-pattern baldness	chr4	80285041	80285541	501	*	6.14	5.08	6.74	-1.66	0.00248	0.00519
chr10	105647558	105647559	rs144529734	3-hydroxypropylmercapturic acid levels in smokers	chr10	105647319	105647819	501	*	5.69	1.98	6.64	-4.66	3.77e-09	2.57e-08
chr12	117495695	117495696	rs137949660	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	chr12	117495215	117495715	501	*	7.66	6.38	8.32	-1.95	0.00752	0.0144
chr1	230136877	230136878	rs11807834	Schizophrenia	chr1	230136576	230137076	501	*	7.96	6.09	8.75	-2.66	1.23e-07	5.83e-07
chr1	155017821	155017822	rs2242194	Schizophrenia	chr1	155017415	155017915	501	*	6.19	5.23	6.76	-1.54	0.00714	0.0137
chr8	27470504	27470505	rs2565065	Schizophrenia	chr8	27470369	27470869	501	*	7.7	4.87	8.6	-3.73	1.45e-12	2.31e-11
chr11	102810218	102810219	rs470530	Post bronchodilator FEV1/FVC ratio in COPD	chr11	102809939	102810439	501	*	4.77	1.86	5.67	-3.8	1.44e-05	4.48e-05
chr2	170814980	170814981	rs45593035	Post bronchodilator FEV1/FVC ratio in COPD	chr2	170814802	170815302	501	*	7.02	2.11	8	-5.89	1.59e-18	1.14e-16
chr6	53391282	53391283	rs147558739	Post bronchodilator FEV1/FVC ratio in COPD	chr6	53391094	53391594	501	*	6.6	3.68	7.5	-3.82	2.68e-11	3.12e-10
chr15	78540694	78540695	rs57064725	Post bronchodilator FEV1	chr15	78540150	78540911	762	*	8.1	7.55	8.49	-0.94	0.0175	0.0309
chr10	80494228	80494229	rs6586028	Post bronchodilator FEV1	chr10	80494015	80494515	501	*	6.88	2.56	7.84	-5.28	5.51e-16	2.09e-14
chr15	78437910	78437911	rs2656070	Post bronchodilator FEV1	chr15	78437862	78438362	501	*	8.95	8.47	9.31	-0.85	0.0157	0.0281
chr4	144453608	144453609	rs6828795	Post bronchodilator FEV1	chr4	144453273	144453773	501	*	5.64	2.48	6.56	-4.08	2.13e-07	9.6e-07
chr1	108041481	108041482	rs12409794	Post bronchodilator FEV1	chr1	108041189	108041689	501	*	5.88	1.89	6.83	-4.94	2.42e-10	2.22e-09
chr13	36029824	36029825	rs140979249	Post bronchodilator FEV1	chr13	36029778	36030278	501	*	8.78	3.12	9.76	-6.65	4.01e-24	1.12e-21
chr12	32657825	32657826	rs181609621	Post bronchodilator FEV1	chr12	32657503	32658003	501	*	5.53	3.53	6.34	-2.81	4.15e-05	0.000119
chr6	169069612	169069613	rs62435770	Loneliness	chr6	169069291	169069791	501	*	6.47	1.29	7.45	-6.16	2.57e-11	3.01e-10
chr6	155327445	155327446	rs9397240	Life satisfaction	chr6	155327432	155327932	501	*	5.39	4.26	6.02	-1.76	0.0108	0.0201
chr15	38627763	38627764	rs59659806	Depression	chr15	38627674	38628174	501	*	7.18	5.62	7.91	-2.29	6.99e-05	0.000192
chr2	58429583	58429584	rs62140779	Neuroticism	chr2	58429413	58429913	501	*	6.17	4.71	6.88	-2.17	0.000327	0.000799
chr1	64848529	64848530	rs114269697	Sum eosinophil basophil counts	chr1	64848040	64848540	501	*	6.68	5.59	7.29	-1.7	0.00718	0.0138
chr2	65429835	65429836	rs7569084	Sum eosinophil basophil counts	chr2	65429752	65430252	501	*	8.07	6.73	8.75	-2.02	1.27e-06	4.87e-06
chr1	108200437	108200438	rs663045	Sum neutrophil eosinophil counts	chr1	108200102	108200602	501	*	7.98	7.24	8.47	-1.24	0.00524	0.0103
chr13	49547375	49547376	rs1570884	Sum neutrophil eosinophil counts	chr13	49547071	49547571	501	*	5.36	3.45	6.15	-2.7	2.91e-05	8.55e-05
chr1	56439852	56439853	rs1999537	Sum basophil neutrophil counts	chr1	56439553	56440053	501	*	6.19	2.8	7.12	-4.33	2.46e-09	1.76e-08
chr10	1110225	1110226	rs10794720	Chronic kidney disease	chr10	1110013	1110513	501	*	5.65	4.62	6.24	-1.62	0.00574	0.0112
chr7	154471917	154471918	rs6977715	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	chr7	154471836	154472336	501	*	5.11	1.69	6.04	-4.35	1.51e-06	5.7e-06
chr4	26002024	26002025	rs71610881	Response to radiotherapy in prostate cancer (overall toxicity)	chr4	26001750	26002250	501	*	8.7	6.82	9.49	-2.66	8.63e-06	2.8e-05
chr19	40811274	40811275	rs185308415	nicotine metabolite ratio in current smokers	chr19	40810828	40811328	501	*	5.76	4.44	6.44	-2	0.000595	0.00139
chr8	103186989	103186990	rs75635567	Late-onset Alzheimer's disease	chr8	103186563	103187063	501	*	5.2	2.22	6.11	-3.89	2.62e-06	9.41e-06
chr11	13335636	13335637	rs10832027	C-reactive protein levels or triglyceride levels (pleiotropy)	chr11	13335188	13335688	501	*	5.4	3.52	6.19	-2.67	4.2e-05	0.00012
chr2	233911933	233911934	rs6724624	Migraine without aura	chr2	233911617	233912117	501	*	4.84	0.85	5.79	-4.94	3.74e-07	1.6e-06
chr13	45833902	45833903	rs9526114	Pneumococcal bacteremia	chr13	45833579	45834079	501	*	8.6	5.74	9.5	-3.76	1.75e-14	4.52e-13
chr1	220879448	220879449	rs796495740	Granulocyte percentage of myeloid white cells	chr1	220879040	220879540	501	*	5.76	2.9	6.65	-3.75	2.33e-08	1.31e-07
chr4	9590409	9590410	rs189421534	Alzheimer disease and age of onset	chr4	9590097	9590597	501	*	4.64	1.82	5.53	-3.71	7.72e-06	2.53e-05
chr1	168939483	168939484	rs10919022	Parental longevity (mother's age at death)	chr1	168939462	168939962	501	*	5.76	2.49	6.68	-4.19	5.87e-06	1.97e-05
chr9	30872221	30872222	rs75880256	Monokine induced by gamma interferon levels	chr9	30872027	30872527	501	*	5.93	3.11	6.82	-3.71	2.04e-09	1.49e-08
chr3	49094441	49094442	rs77440492	Macrophage inflammatory protein 1b levels	chr3	49093983	49094483	501	*	9.39	8.88	9.77	-0.89	0.0223	0.0386
chr14	69023286	69023287	rs28535566	Tumor necrosis factor beta levels	chr14	69022988	69023488	501	*	5.02	1.51	5.95	-4.45	2.67e-07	1.18e-06
chr8	55901862	55901863	rs1027989	Blood pressure traits (multi-trait analysis)	chr8	55901605	55902105	501	*	5.01	3.57	5.72	-2.15	0.00335	0.00684
chr11	116742944	116742945	rs12280753	Cardiovascular risk factors (age interaction)	chr11	116742728	116743228	501	*	6.08	4.34	6.84	-2.51	0.000211	0.000531
chr9	86947439	86947440	rs7859734	Borderline personality disorder	chr9	86947430	86948160	731	*	8.4	7.86	8.79	-0.93	0.0245	0.0421
chr15	61525012	61525013	rs532282237	Skin pigmentation	chr15	61524887	61525387	501	*	7.31	1.69	8.29	-6.6	0.000123	0.000322
chr16	67951803	67951804	rs2292318	HDL cholesterol levels	chr16	67951428	67951928	501	*	6.1	5.09	6.69	-1.61	0.00933	0.0175
chr3	196178239	196178240	rs7640081	Blood osmolality (transformed sodium)	chr3	196177934	196178434	501	*	6.58	5.37	7.23	-1.86	0.00122	0.0027
chr4	158177632	158177633	rs13126694	Blood osmolality (transformed sodium)	chr4	158177364	158177864	501	*	5.25	2.15	6.16	-4.02	4.42e-06	1.52e-05
chr8	81818922	81818923	rs7833790	Diastolic blood pressure	chr8	81818502	81819002	501	*	5.81	3.4	6.67	-3.27	2.92e-06	1.04e-05
chr1	37990219	37990220	rs4360494	Pulse pressure	chr1	37989872	37990372	501	*	7.95	7.26	8.42	-1.15	0.0047	0.00933
chr17	7834013	7834014	rs12945870	Hemoglobin concentration	chr17	7833666	7834166	501	*	6.85	5.99	7.38	-1.39	0.00879	0.0166
chr9	88777772	88777773	rs142550358	Lymphocyte counts	chr9	88777648	88778148	501	*	4.6	0.73	5.55	-4.83	2.68e-06	9.6e-06
chr1	161185602	161185603	rs4575098	Monocyte percentage of white cells	chr1	161185335	161185835	501	*	7.33	5.88	8.04	-2.16	0.00149	0.00325
chr3	46421418	46421419	rs34042186	Monocyte percentage of white cells	chr3	46421400	46421900	501	*	5.45	4.6	5.98	-1.37	0.0209	0.0365
chr3	3849622	3849623	rs66515854	beta-nerve growth factor levels	chr3	3849358	3849858	501	*	7	3.45	7.94	-4.48	5.01e-07	2.08e-06
chr16	3400907	3400908	rs1878931	Body mass index (adult)	chr16	3400896	3401396	501	*	8.25	7.23	8.85	-1.62	3.19e-05	9.32e-05
chr2	106885458	106885459	rs76390238	Growth-regulated protein alpha levels	chr2	106885319	106885819	501	*	6.42	2.22	7.38	-5.17	5.75e-14	1.31e-12
chr2	214088924	214088925	rs7578892	Interleukin-5 levels	chr2	214088529	214089029	501	*	5.45	2.53	6.35	-3.83	5.69e-06	1.91e-05
chr9	4500231	4500232	rs7860087	Interleukin-17 levels	chr9	4499879	4500379	501	*	7.02	4.43	7.9	-3.47	1.94e-09	1.42e-08
chr10	104924411	104924412	rs12765671	Interleukin-16 levels	chr10	104924056	104924556	501	*	5.93	4.42	6.65	-2.23	0.000295	0.000725
chr11	127473986	127473987	rs187327935	Post bronchodilator FEV1/FVC ratio	chr11	127473981	127474481	501	*	4.39	0.33	5.34	-5.01	3.68e-06	1.28e-05
chr11	77322906	77322907	rs146103351	Post bronchodilator FEV1/FVC ratio	chr11	77322430	77322930	501	*	6.6	5.63	7.17	-1.54	0.0121	0.0221
chr6	10195190	10195191	rs189431351	Post bronchodilator FEV1/FVC ratio	chr6	10194843	10195343	501	*	5.71	3.27	6.58	-3.31	1.29e-06	4.92e-06
chr18	41458077	41458078	rs184167040	Post bronchodilator FEV1/FVC ratio	chr18	41457696	41458196	501	*	5.51	4.52	6.09	-1.57	0.0109	0.0202
chr3	159127152	159127153	rs138869894	Post bronchodilator FEV1/FVC ratio	chr3	159126685	159127185	501	*	6.77	3.72	7.68	-3.96	8.77e-12	1.15e-10
chr20	58882287	58882288	rs186485497	Post bronchodilator FEV1/FVC ratio	chr20	58882271	58882771	501	*	4.93	3.92	5.52	-1.6	0.0128	0.0233
chr4	104901402	104901403	rs73838643	Post bronchodilator FEV1/FVC ratio	chr4	104901397	104901897	501	*	6.56	4.98	7.3	-2.32	0.000188	0.000478
chr14	52919724	52919725	rs79534246	Post bronchodilator FEV1/FVC ratio	chr14	52919305	52919805	501	*	5.27	3.28	6.08	-2.8	0.000163	0.000421
chr14	68794755	68794756	rs2236262	Multiple sclerosis	chr14	68794378	68794878	501	*	6.81	2.66	7.77	-5.11	1.88e-16	8.04e-15
chr1	198861813	198861814	rs113116201	Multiple sclerosis	chr1	198861656	198862156	501	*	6.79	4.19	7.67	-3.48	1.43e-10	1.39e-09
chr2	38523145	38523146	rs77489951	Body mass index	chr2	38522724	38523224	501	*	8.15	2.78	9.14	-6.36	9.34e-28	5.82e-25
chr2	199851396	199851397	rs796364	Schizophrenia	chr2	199850940	199851440	501	*	8.68	8.12	9.08	-0.96	0.0172	0.0305
chr20	38718108	38718109	rs1075195	Schizophrenia	chr20	38717687	38718187	501	*	6.06	1.29	7.03	-5.74	6.26e-10	5.15e-09
chr16	30875322	30875323	rs897984	Dementia with Lewy bodies	chr16	30875119	30875619	501	*	7.13	6.09	7.73	-1.64	0.00138	0.00302
chr1	56255862	56255863	rs1417770	Lobe attachment (rater-scored or self-reported)	chr1	56255512	56256012	501	*	6.95	1.62	7.93	-6.31	2.15e-16	9.06e-15
chr9	108612004	108612005	rs28452995	Lobe attachment (rater-scored or self-reported)	chr9	108611753	108612253	501	*	7.63	4.72	8.53	-3.81	3.03e-08	1.66e-07
chr12	28568792	28568793	rs1355471	Polycystic ovary syndrome	chr12	28568654	28569154	501	*	7.8	3.63	8.76	-5.14	5.12e-15	1.5e-13
chr10	52652733	52652734	rs1159798	Total body bone mineral density	chr10	52652333	52652833	501	*	8.99	7.91	9.59	-1.68	0.00228	0.00481
chr15	67254963	67254964	rs3743347	Total body bone mineral density	chr15	67254483	67254983	501	*	8.6	7.94	9.06	-1.12	0.00387	0.0078
chr18	77003313	77003314	rs470903	Paclitaxel disposition in epithelial ovarian cancer	chr18	77002955	77003455	501	*	6.16	2.66	7.1	-4.44	1.08e-09	8.42e-09
chr1	156193927	156193928	rs2241111	Paclitaxel disposition in epithelial ovarian cancer	chr1	156193731	156194231	501	*	9.12	8.18	9.69	-1.5	0.00069	0.00159
chr9	22050899	22050900	rs944800	Glaucoma (primary open-angle)	chr9	22050482	22050982	501	*	6.06	2.74	6.98	-4.24	2.14e-10	1.99e-09
chr13	108519067	108519068	rs11616603	Alcohol dependence symptom count	chr13	108518971	108519471	501	*	7.08	2.84	8.04	-5.2	3.7e-14	8.82e-13
chrX	69564858	69564859	rs55846652	Tooth agenesis (maxillary lateral incisors)	chrX	69564695	69565453	759	*	7.86	2.19	8.84	-6.65	8.64e-26	3.62e-23
chr19	572671	572672	rs201850688	Alzheimer's disease (late onset)	chr19	572292	572792	501	*	7.19	6.37	7.71	-1.34	0.00587	0.0115
chr18	49629266	49629267	rs768116521	Apolipoprotein A1 levels	chr18	49628910	49629410	501	*	7.59	6.34	8.25	-1.92	1.39e-05	4.35e-05
chr1	26692640	26692641	rs112203773	Neutrophil percentage of white cells	chr1	26692225	26692725	501	*	7.02	6.15	7.55	-1.4	0.0156	0.028
chr3	72238120	72238121	rs10587701	Immature fraction of reticulocytes	chr3	72238107	72238607	501	*	6.15	3.54	7.02	-3.48	9.61e-07	3.77e-06
chr8	107381731	107381732	rs1654723	Immature fraction of reticulocytes	chr8	107381284	107381784	501	*	6.26	3.02	7.18	-4.16	1.61e-11	1.98e-10
chr8	141222157	141222158	rs59918340	Immature fraction of reticulocytes	chr8	141221707	141222207	501	*	6.24	4.69	6.97	-2.28	0.000334	0.000816
chr6	161872612	161872613	rs34139189	Fear of minor pain	chr6	161872385	161872885	501	*	7.25	2.31	8.23	-5.92	3.61e-13	6.71e-12
chr15	78944951	78944952	rs2289702	Narcolepsy	chr15	78944813	78945313	501	*	6.25	4.13	7.07	-2.94	2.57e-07	1.14e-06
chr4	15707569	15707570	rs2302465	Blood protein levels	chr4	15707309	15707809	501	*	5.53	1.51	6.48	-4.98	2.31e-09	1.66e-08
chr4	186229652	186229653	rs1511802	Blood protein levels	chr4	186229523	186230023	501	*	6.26	2.59	7.21	-4.62	1.3e-07	6.13e-07
chr16	71934798	71934799	rs17286411	Blood protein levels	chr16	71934527	71935027	501	*	5.99	3.92	6.8	-2.88	7.34e-06	2.42e-05
chr2	54115818	54115819	rs2287641	Cannabis dependence symptom count	chr2	54115531	54116031	501	*	9.62	9.18	9.95	-0.77	0.0192	0.0338
chr3	46899626	46899627	rs2242116	Birth weight	chr3	46899400	46899900	501	*	4.8	2.53	5.64	-3.12	7.95e-05	0.000216
chr3	138403078	138403079	rs3732837	Coronary artery disease	chr3	138402654	138403154	501	*	5.24	2.66	6.11	-3.45	1.15e-06	4.46e-06
chr1	200676945	200676946	rs6700559	Coronary artery disease	chr1	200676744	200677244	501	*	6.77	3.14	7.71	-4.57	1.87e-11	2.27e-10
chr5	9545986	9545987	rs112941079	Coronary artery disease	chr5	9545827	9546327	501	*	6.51	4.98	7.24	-2.26	0.00913	0.0172
chr6	32666690	32666691	rs3891175	Autoimmune hepatitis in primary sclerosing cholangitis	chr6	32666482	32666982	501	*	4.77	1.88	5.66	-3.78	0.000105	0.000278
chr6	129575356	129575357	rs10457526	Response to alcohol consumption (flushing response)	chr6	129575212	129575712	501	*	5.72	3.06	6.61	-3.54	1.41e-07	6.61e-07
chr2	3470314	3470315	rs35067331	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	chr2	3469972	3470472	501	*	6.12	5.38	6.6	-1.22	0.0196	0.0344
chr17	78112992	78112993	rs2253277	Serum uric acid levels	chr17	78112532	78113032	501	*	5.18	4.13	5.79	-1.66	0.0192	0.0337
chr3	28151142	28151143	rs75233056	Plasma trimethyllysine levels	chr3	28150831	28151331	501	*	6.69	5.17	7.41	-2.24	9.69e-06	3.12e-05
chr5	129362750	129362751	rs115630272	Intraocular pressure	chr5	129362480	129362980	501	*	5.49	2.15	6.41	-4.27	3.09e-07	1.35e-06
chr12	122023660	122023661	rs7954584	Mean corpuscular volume	chr12	122023285	122023785	501	*	5.66	4.5	6.3	-1.8	0.00189	0.00404
chr2	31254972	31254973	rs655029	Mean platelet volume	chr2	31254178	31255111	934	*	7.39	5.72	8.14	-2.41	8.41e-08	4.14e-07
chr17	47531904	47531905	rs62073968	Mean platelet volume	chr17	47531884	47532384	501	*	4.13	2.35	4.9	-2.55	0.00897	0.0169
chr12	88449697	88449698	rs11104881	Neutrophil count	chr12	88449646	88450146	501	*	4.87	3.29	5.6	-2.31	0.000668	0.00155
chr20	19935125	19935126	rs181853315	Platelet distribution width	chr20	19934788	19935288	501	*	5.62	1.29	6.58	-5.29	5.73e-10	4.77e-09
chr1	20350704	20350705	rs10916772	Psychosis proneness (perceptual aberration scale)	chr1	20350239	20350739	501	*	7.63	2.04	8.61	-6.57	4.99e-18	3.13e-16
chr13	75217887	75217888	rs75424961	Pneumonia	chr13	75217812	75218312	501	*	5.77	4.36	6.47	-2.11	0.00117	0.0026
chr6	27891059	27891060	rs200972	Urinary tract infection frequency	chr6	27890603	27891103	501	*	7.19	6.27	7.74	-1.48	0.0294	0.0496
chr9	5510838	5510839	rs113352172	Blood protein levels	chr9	5510679	5511179	501	*	5.44	1.69	6.38	-4.69	1.73e-08	1e-07
chr10	50039928	50039929	rs114001906	Blood protein levels	chr10	50039653	50040153	501	*	4.93	2	5.83	-3.83	7.14e-06	2.35e-05
chr14	52016050	52016051	rs1151582	Blood protein levels	chr14	52015573	52016073	501	*	5.42	3.1	6.26	-3.16	5.04e-05	0.000142
chr17	52136371	52136372	rs117399000	Blood protein levels	chr17	52136144	52136644	501	*	6.43	5.19	7.08	-1.89	0.00141	0.00309
chr6	33080683	33080684	rs12722013	Blood protein levels	chr6	33080114	33080945	832	*	8.07	6.73	8.75	-2.01	0.000238	0.000594
chr16	16232314	16232315	rs144648477	Blood protein levels	chr16	16232256	16232756	501	*	5.22	3.74	5.94	-2.2	0.00175	0.00378
chr8	33473169	33473170	rs2732317	Blood protein levels	chr8	33472935	33473435	501	*	8.73	8.2	9.12	-0.92	0.0286	0.0483
chr1	22691071	22691072	rs294227	Blood protein levels	chr1	22690969	22691469	501	*	5.66	1.69	6.61	-4.91	5.03e-08	2.61e-07
chr17	28343601	28343602	rs3093692	Blood protein levels	chr17	28343553	28344053	501	*	5.61	0.73	6.58	-5.85	3.82e-10	3.33e-09
chr19	44927023	44927024	rs5112	Blood protein levels	chr19	44927012	44927512	501	*	4.49	0.73	5.43	-4.7	2.41e-06	8.72e-06
chr11	207462	207463	rs11245998	Mean corpuscular hemoglobin concentration	chr11	207298	207798	501	*	9.23	8.73	9.6	-0.87	0.0142	0.0256
chr1	155227477	155227478	rs2974929	Blood urea nitrogen levels	chr1	155227331	155227831	501	*	9.05	8.5	9.44	-0.94	0.0157	0.0281
chr1	155227811	155227812	rs2990246	Creatinine levels	chr1	155227331	155227831	501	*	9.05	8.5	9.44	-0.94	0.0157	0.0281
chr18	26813249	26813250	rs16942751	Creatinine levels	chr18	26813001	26813501	501	*	5.97	4.15	6.75	-2.6	0.000161	0.000415
chr5	3595864	3595865	rs6420041	Glomerular filtration rate	chr5	3595631	3596131	501	*	4.54	1.86	5.43	-3.56	6.53e-05	0.00018
chr6	131765353	131765354	rs17060705	Phosphorus levels	chr6	131764934	131765434	501	*	6.04	3.6	6.9	-3.3	2.56e-06	9.2e-06
chr6	33737578	33737579	rs73743323	Phosphorus levels	chr6	33737229	33737729	501	*	5.16	3.8	5.84	-2.04	0.00234	0.00493
